PortfoliosLab logoPortfoliosLab logo
MRK vs. DOW
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MRK vs. DOW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merck & Co., Inc. (MRK) and Dow Inc. (DOW). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MRK achieves a 14.39% return, which is significantly lower than DOW's 49.52% return.


MRK

1D
-1.05%
1M
7.31%
YTD
14.39%
6M
22.75%
1Y
56.85%
3Y*
5.78%
5Y*
13.57%
10Y*
11.61%

DOW

1D
0.68%
1M
-6.30%
YTD
49.52%
6M
52.92%
1Y
26.06%
3Y*
-7.69%
5Y*
-8.18%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MRK vs. DOW - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
MRK
Merck & Co., Inc.
14.39%9.79%-6.26%1.01%49.42%1.75%-7.20%13.06%
DOW
Dow Inc.
49.52%-37.38%-22.79%14.71%-6.65%6.81%7.88%14.82%

Correlation

The correlation between MRK and DOW is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Mar 21, 2019

0.20

Fundamentals

Market Cap

MRK:

$295.45B

DOW:

$24.67B

EPS

MRK:

$3.58

DOW:

-$3.86

PS Ratio

MRK:

4.54

DOW:

0.62

PB Ratio

MRK:

6.44

DOW:

1.62

Total Revenue (TTM)

MRK:

$65.59B

DOW:

$39.33B

Gross Profit (TTM)

MRK:

$49.79B

DOW:

$2.42B

EBITDA (TTM)

MRK:

$22.69B

DOW:

$840.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MRK vs. DOW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRK
MRK Risk / Return Rank: 9090
Overall Rank
MRK Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 9090
Sortino Ratio Rank
MRK Omega Ratio Rank: 8686
Omega Ratio Rank
MRK Calmar Ratio Rank: 9292
Calmar Ratio Rank
MRK Martin Ratio Rank: 9191
Martin Ratio Rank

DOW
DOW Risk / Return Rank: 5858
Overall Rank
DOW Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
DOW Sortino Ratio Rank: 5656
Sortino Ratio Rank
DOW Omega Ratio Rank: 5656
Omega Ratio Rank
DOW Calmar Ratio Rank: 6060
Calmar Ratio Rank
DOW Martin Ratio Rank: 5959
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRK vs. DOW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Dow Inc. (DOW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MRKDOWDifference
Sharpe ratioReturn per unit of total volatility

+1.57

Sortino ratioReturn per unit of downside risk

+2.00

Omega ratioGain probability vs. loss probability

1.36

1.13

+0.23

Calmar ratioReturn relative to maximum drawdown

5.03

0.82

+4.21

Martin ratioReturn relative to average drawdown

12.59

1.54

+11.05

MRK vs. DOW - Sharpe Ratio Comparison

The current MRK Sharpe Ratio is 2.10, which is higher than the DOW Sharpe Ratio of 0.53. The chart below compares the historical Sharpe Ratios of MRK and DOW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MRKDOWDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.10

0.53

+1.57

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.58

-0.25

+0.82

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

0.48

0.01

+0.47

Drawdowns

MRK vs. DOW - Drawdown Comparison

The maximum MRK drawdown since its inception was -68.61%, which is greater than DOW's maximum drawdown of -64.37%. Use the drawdown chart below to compare losses from any high point for MRK and DOW.


Loading charts...

Drawdown Indicators


MRKDOWDifference

Max Drawdown

Largest peak-to-trough decline

-68.61%

-64.37%

-4.24%

Max Drawdown (1Y)

Largest decline over 1 year

-11.37%

-32.02%

+20.65%

Max Drawdown (3Y)

Largest decline over 3 years

-43.44%

-62.16%

+18.72%

Max Drawdown (5Y)

Largest decline over 5 years

-43.44%

-64.37%

+20.93%

Max Drawdown (10Y)

Largest decline over 10 years

-43.44%

Current Drawdown

Current decline from peak

-4.65%

-38.56%

+33.91%

Average Drawdown

Average peak-to-trough decline

-18.84%

-22.75%

+3.91%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.53%

16.93%

-12.40%

Volatility

MRK vs. DOW - Volatility Comparison

Merck & Co., Inc. (MRK) and Dow Inc. (DOW) have volatilities of 9.44% and 9.44%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MRKDOWDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.44%

9.44%

0.00%

Volatility (6M)

Calculated over the trailing 6-month period

18.14%

33.01%

-14.87%

Volatility (1Y)

Calculated over the trailing 1-year period

27.30%

49.50%

-22.20%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.71%

33.52%

-9.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.96%

38.65%

-15.69%

Dividends

MRK vs. DOW - Dividend Comparison

MRK's dividend yield for the trailing twelve months is around 2.78%, less than DOW's 4.09% yield.


PositionTTM20252024202320222021202020192018201720162015
DOW
Dow Inc.
4.09%8.98%6.98%5.11%5.56%4.94%5.05%3.84%0.00%0.00%0.00%0.00%
MRK
Merck & Co., Inc.
2.78%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%

Financials

MRK vs. DOW - Financials Comparison

This section allows you to compare key financial metrics between Merck & Co., Inc. and Dow Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B12.00B14.00B16.00B18.00B20222023202420252026
16.29B
9.79B
(MRK) Total Revenue
(DOW) Total Revenue
Values in USD except per share items

MRK vs. DOW - Profitability Comparison

The chart below illustrates the profitability comparison between Merck & Co., Inc. and Dow Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
81.9%
6.5%
Portfolio components
MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.

DOW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dow Inc. reported a gross profit of 640.00M and revenue of 9.79B. Therefore, the gross margin over that period was 6.5%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.

DOW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dow Inc. reported an operating income of -31.00M and revenue of 9.79B, resulting in an operating margin of -0.3%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.

DOW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dow Inc. reported a net income of -445.00M and revenue of 9.79B, resulting in a net margin of -4.5%.


Frequently Asked Questions


MRK and DOW have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DOW has higher volatility (9.44%) compared to MRK (9.44%). In terms of maximum drawdown, MRK dropped -68.61% vs DOW's -64.37%.

MRK currently has the higher Sharpe Ratio (2.10 vs 0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MRK and DOW

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer